Release and bioactivity of bone morphogenetic protein-2 are affected by scaffold binding techniques in vitro and in vivo.
暂无分享,去创建一个
Yang Sun | Joachim Nickel | Zhe Xing | Ying Xue | Anna Finne-Wistrand | J. Nickel | H. Lygre | A. Krueger | A. Finne‐Wistrand | K. Mustafa | Xujun Wu | Thilo Waag | Doris Steinmüller-Nethl | Anke Krueger | Kamal Mustafa | Z. Xing | Yang Sun | A. Døskeland | D. Steinmüller-Nethl | Salwa Suliman | Torbjorn O Pedersen | Anne P Døskeland | Henning Lygre | Salwa Suliman | Xujun Wu | T. O. Pedersen | Thilo Waag | Y. Xue | D. Steinmüller‐Nethl
[1] Andrés J. García,et al. Extracellular matrix-mimetic adhesive biomaterials for bone repair. , 2011, Journal of biomedical materials research. Part A.
[2] 王靖,et al. Bone regeneration using cell-mediated responsive degradable PEG-based scaffolds incorporating with rhBMP-2 , 2012 .
[3] I. Noh,et al. Effects of recombinant human bone morphogenic protein-2 and human bone marrow-derived stromal cells on in vivo bone regeneration of chitosan-poly(ethylene oxide) hydrogel. , 2013, Journal of biomedical materials research. Part A.
[4] A. Finne‐Wistrand,et al. Comparison of Short-Run Cell Seeding Methods for Poly(L-Lactide-co-1,5-Dioxepan-2-one) Scaffold Intended for Bone Tissue Engineering , 2011, The International journal of artificial organs.
[5] W. Sebald,et al. Sustained Release Carriers Used to Delivery Bone Morphogenetic Proteins in the Bone Healing Process , 2008, Anatomia, histologia, embryologia.
[6] M. Shokrgozar,et al. Nanodiamonds for surface engineering of orthopedic implants: Enhanced biocompatibility in human osteosarcoma cell culture , 2013 .
[7] Dong-Woo Cho,et al. In vitro and in vivo evaluation of bone formation using solid freeform fabrication-based bone morphogenic protein-2 releasing PCL/PLGA scaffolds , 2014, Biomedical materials.
[8] G. Niebur,et al. Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. , 2012, European cells & materials.
[9] Glenn D Prestwich,et al. Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. , 2012, Biomaterials.
[10] Yang Sun,et al. Biological effects of functionalizing copolymer scaffolds with nanodiamond particles. , 2013, Tissue engineering. Part A.
[11] C. Huck,et al. Nanocrystalline diamond--an excellent platform for life science applications. , 2007, Journal of nanoscience and nanotechnology.
[12] Andreas Ebner,et al. The role of oxygen termination of nanocrystalline diamond on immobilisation of BMP-2 and subsequent bone formation. , 2008, Biomaterials.
[13] R. Reis,et al. Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery. , 2013, Tissue engineering. Part B, Reviews.
[14] E. Ōsawa,et al. Multi-protein Delivery by Nanodiamonds Promotes Bone Formation , 2013, Journal of dental research.
[15] A. Albertsson,et al. Biocompatibility of Polyester Scaffolds with Fibroblasts and Osteoblast-like Cells for Bone Tissue Engineering , 2010 .
[16] A. Krueger,et al. Functionality is Key: Recent Progress in the Surface Modification of Nanodiamond , 2012 .
[17] S. Gygi,et al. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Ozawa,et al. Unusually tight aggregation in detonation nanodiamond: Identification and disintegration , 2005 .
[19] Eyal Zussman,et al. Slow-release human recombinant bone morphogenetic protein-2 embedded within electrospun scaffolds for regeneration of bone defect: in vitro and in vivo evaluation. , 2011, Tissue engineering. Part A.
[20] D. Mooney,et al. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments , 2011, Journal of The Royal Society Interface.
[21] S. Venkatraman,et al. Release Retardation of Model Protein on Polyelectrolyte-Coated PLGA Nano- and Microparticles , 2014, PloS one.
[22] J. Jansen,et al. Non-glycosylated BMP-2 can induce ectopic bone formation at lower concentrations compared to glycosylated BMP-2. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[23] A. Albertsson,et al. Effect of endothelial cells on bone regeneration using poly(L-lactide-co-1,5-dioxepan-2-one) scaffolds. , 2011, Journal of biomedical materials research. Part A.
[24] X. Zhu,et al. Polymer microspheres for controlled drug release. , 2004, International journal of pharmaceutics.
[25] Qin Liu,et al. Improvement in the delivery system of bone morphogenetic protein-2: a new approach to promote bone formation , 2012, Biomedical materials.
[26] Mark C Simmonds,et al. Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion , 2013, Annals of Internal Medicine.
[27] Yubo Fan,et al. Controlled release of BSA by microsphere-incorporated PLGA scaffolds under cyclic loading , 2011 .
[28] E. Hunziker,et al. The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. , 2010, Biomaterials.
[29] Herbert Riechelmann,et al. Sheep as a Large Animal Model for Middle and Inner Ear Implantable Hearing Devices: A Feasibility Study in Cadavers , 2012, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[30] U. Lerner,et al. Osteoclast progenitor cells present in significant amounts in mouse calvarial osteoblast isolations and osteoclastogenesis increased by BMP-2. , 2013, Bone.
[31] A. Priezzhev,et al. Adsorption of human blood plasma on nanodiamond and its influence on activated partial thromboplastin time , 2013 .
[32] A. Krueger. New Carbon Materials: Biological Applications of Functionalized Nanodiamond Materials , 2008 .
[33] H. Yoshikawa,et al. Bone Morphogenetic Proteins in Bone Stimulate Osteoclasts and Osteoblasts During Bone Development , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] E. Hunziker,et al. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. , 2005, Bone.
[35] C. Susin,et al. Effect of rhBMP-2 dose on bone formation/maturation in a rat critical-size calvarial defect model. , 2014, Journal of clinical periodontology.
[36] Daocheng Wu,et al. Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement , 2008, Journal of materials science. Materials in medicine.
[37] Ann-Christine Albertsson,et al. A strategy for the covalent functionalization of resorbable polymers with heparin and osteoinductive growth factor. , 2008, Biomacromolecules.
[38] A Wennerberg,et al. Determining optimal surface roughness of TiO(2) blasted titanium implant material for attachment, proliferation and differentiation of cells derived from human mandibular alveolar bone. , 2001, Clinical oral implants research.
[39] S. Glassman,et al. Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.
[40] Stuart B Goodman,et al. The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro. , 2007, Tissue engineering.
[41] A. Albertsson,et al. Osteogenic Differentiation by Rat Bone Marrow Stromal Cells on Customized Biodegradable Polymer Scaffolds , 2010 .
[42] M C Sogayar,et al. Bone Morphogenetic Proteins , 2014, Journal of dental research.
[43] C. Vedeler,et al. Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM. , 2013, Journal of proteomics.
[44] Rami Mosheiff,et al. Tissue engineering approaches for bone repair: concepts and evidence. , 2011, Injury.
[45] Yasuhiko Tabata,et al. Bone Regeneration Using a Bone Morphogenetic Protein-2 Saturated Slow-Release Gelatin Hydrogel Sheet: Evaluation in a Canine Orbital Floor Fracture Model , 2010, Annals of plastic surgery.
[46] C. Huck,et al. Strong binding of bioactive BMP-2 to nanocrystalline diamond by physisorption. , 2006, Biomaterials.
[47] S. Hollister,et al. Chemically-conjugated bone morphogenetic protein-2 on three-dimensional polycaprolactone scaffolds stimulates osteogenic activity in bone marrow stromal cells. , 2010, Tissue engineering. Part A.
[48] Georg N Duda,et al. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. , 2012, Advanced drug delivery reviews.
[49] A. Liese,et al. Novel immobilization routes for the covalent binding of an alcohol dehydrogenase from Rhodococcus ruber DSM 44541 , 2008 .
[50] William V Giannobile,et al. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[51] Y. Missirlis,et al. Protein–material interactions: From micro-to-nano scale , 2008 .
[52] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[53] S. Santavirta,et al. Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.
[54] H. Genant,et al. Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures , 2010 .
[55] E. Hunziker,et al. Osseointegration: the slow delivery of BMP-2 enhances osteoinductivity. , 2012, Bone.
[56] S. Bhang,et al. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. , 2008, Biochemical and biophysical research communications.
[57] A. Albertsson,et al. In vitro and in vivo degradation profile of aliphatic polyesters subjected to electron beam sterilization. , 2011, Acta biomaterialia.
[58] Yury Gogotsi,et al. Adsorption of drugs on nanodiamond: toward development of a drug delivery platform. , 2013, Molecular pharmaceutics.
[59] Michael J Yaszemski,et al. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. , 2008, Biomaterials.
[60] Erin L. Hsu,et al. A comparative evaluation of factors influencing osteoinductivity among scaffolds designed for bone regeneration. , 2013, Tissue engineering. Part A.
[61] T. Kirsch,et al. BMP‐2 antagonists emerge from alterations in the low‐affinity binding epitope for receptor BMPR‐II , 2000, The EMBO journal.